Read More Analyst Ratings News Price Target Jefferies Maintains Buy on Signature Bank, Lowers Price Target to $205 By Benzinga Newsdesk September 8, 8:51 AM Jefferies analyst Casey Haire maintains Signature Bank (NASDAQ:SBNY) with a Buy and lowers the price target from $248 to $205. SBNY
Read More Biotech General Health Care Large Cap News China Approves AstraZeneca-Sanofi’s Respiratory Syncytial Virus Drug To Prevent Infection In Infants By Vandana Singh January 2, 8:53 AM Tuesday, China's National Medical Products Administration approved AstraZeneca Plc (NASD AZN
Read More Analyst Ratings News Price Target B. Riley Securities Maintains Buy on Cherry Hill Mortgage, Lowers Price Target to $7 By Benzinga Newsdesk October 25, 9:49 AM B. Riley Securities analyst Matt Howlett maintains Cherry Hill Mortgage (NYSE:CHMI) with a Buy and lowers the price target from $8 to $7. CHMI
Read More Earnings News Mastech Holdings Q3 EPS $0.33 Misses $0.38 Estimate, Sales $63.15M Miss $64.11M Estimate By Benzinga Newsdesk November 2, 7:08 AM Mastech Holdings (AMEX:MHH) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.38 by 13.16 percent. This is a 13.16 percent decrease over earnings of $0.38 per share from the MHH